Editorial: Alternative Therapeutics Against Antimicrobial-Resistant Pathogens.

Rebecca Thombre, Kamlesh Jangid, Ravi Shukla, Noton Kumar Dutta
Author Information
  1. Rebecca Thombre: Department of Biotechnology, Modern College of Arts, Science and Commerce, Pune, India.
  2. Kamlesh Jangid: National Centre for Microbial Resource, National Centre for Cell Science, Savitribai Phule Pune University Campus, Pune, India.
  3. Ravi Shukla: NanoBiotechnology Research Laboratory, RMIT University, Melbourne, VIC, Australia.
  4. Noton Kumar Dutta: Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, United States.

Abstract

No abstract text available.

Keywords

References

  1. J Antimicrob Chemother. 2016 Jun;71(6):1570-7 [PMID: 26903278]
  2. Antimicrob Agents Chemother. 2014 Jul;58(7):4048-53 [PMID: 24798290]
  3. Front Microbiol. 2010 Dec 08;1:134 [PMID: 21687759]
  4. Int J Antimicrob Agents. 2010 Oct;36(4):295-302 [PMID: 20591629]
  5. J Infect Dis. 2019 Apr 19;219(10):1518-1524 [PMID: 30590592]
  6. FEMS Microbiol Rev. 2018 Nov 1;42(6):781-804 [PMID: 30085063]
  7. PLoS One. 2010 Apr 08;5(4):e10069 [PMID: 20386700]
  8. Eur J Clin Microbiol Infect Dis. 2009 Aug;28(8):881-91 [PMID: 19399540]
  9. Front Microbiol. 2016 Sep 13;7:1424 [PMID: 27679615]
  10. Int J Antimicrob Agents. 2007 Sep;30(3):242-9 [PMID: 17644318]

Word Cloud

Created with Highcharts 10.0.0antimicrobialcompoundsEditorial:AlternativeTherapeuticsAntimicrobial-ResistantPathogensalternativetherapyagentsresistanceAMRmultidrug-resistanceMDRnanomaterialsnanoparticlesnovelplantbased

Similar Articles

Cited By (5)